Related Experiment Video

Updated: May 27, 2026

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells
06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

A MEK-independent role for CRAF in mitosis and tumor progression

Ainhoa Mielgo1, Laetitia Seguin, Miller Huang

  • 1Department of Pathology, Moores Cancer Center, University of California San Diego, La Jolla, California, USA.

Nature Medicine
|November 15, 2011
PubMed

Insights

RAF kinases have a newly discovered role in tumor growth independent of the MEK-ERK pathway. CRAF phosphorylation at Ser338 and its spindle localization are crucial for cell division and tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • RAF kinases are key regulators of cell proliferation and survival, often dysregulated in cancer.
  • Their known role in proliferation involves activating MEK (mitogen-activated protein kinase kinase 1) and ERK (mitogen-activated protein kinase 1).

Purpose of the Study:

  • To investigate a MEK-independent role of RAF in tumor growth.
  • To identify novel therapeutic targets and biomarkers for RAF-driven cancers.

Main Methods:

  • Investigated CRAF phosphorylation at Ser338 and its localization in mitotic cells using in vitro and in vivo models, including human cancer biopsies.
  • Utilized allosteric and ATP-competitive RAF inhibitors to assess their impact on CRAF activity and cell cycle progression.
  • Examined the interaction of CRAF with Aurora kinase A and Polo-like kinase 1 (Plk1) during mitosis.

Main Results:

  • Discovered that phosphorylated CRAF (p-Ser338 CRAF) localizes to the mitotic spindle in proliferating tumor cells.
  • Allosteric RAF inhibitors, but not ATP-competitive ones, blocked p-Ser338 CRAF localization and induced prometaphase cell-cycle arrest.
  • p-Ser338 CRAF was identified as a potential biomarker for tumor progression and a marker for allosteric RAF blockade.
  • CRAF interacts with Aurora-A and Plk1, and inhibition of p-Ser338 CRAF impairs Plk1 activation, leading to prometaphase arrest.

Conclusions:

  • RAF kinases play a critical role in tumor progression through a MEK-independent pathway involving mitotic spindle localization.
  • Targeting p-Ser338 CRAF with allosteric inhibitors offers a novel therapeutic strategy for cancer.
  • p-Ser338 CRAF serves as a valuable biomarker for monitoring treatment response to allosteric RAF inhibitors.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Related Concept Videos

M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...